Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherCommentary

Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit

Joanny Salvas, Petra Merker, Mike Dingle, Cedric Joossen, Chris Knutsen, David Govezensky, Jim Cannon, Philip Villari, Anthony M Cundell, Victoria Navarro, Margit Franz-Riethdorf and Allison Scott
PDA Journal of Pharmaceutical Science and Technology July 2023, pdajpst.2022.012790; DOI: https://doi.org/10.5731/pdajpst.2022.012790
Joanny Salvas
1 Pfizer, Kirkland, QC, Canada / BioPhorum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joanny.salvas@pfizer.com
Petra Merker
2 Bayer AG, Mullerstr. 178, D-13353 Berlin, Germany / BioPhorum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: petra.merker@bayer.com
Mike Dingle
3 TSI Incorporated, 500 Cardigan Road, Shoreview, MN 55126 USA / PEMM;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael.dingle@tsi.com
Cedric Joossen
4 Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium / OWBA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cjoossen@its.jnj.com
Chris Knutsen
5 Bristol-Myers Squibb, New Brunswick, NJ, USA / BioPhorum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chris.knutsen@bms.com
David Govezensky
6 Bio-Technology General (Israel) Ltd., POB 571, Be'er Tuvia Industrial Zone, Kiryat Malachi 8310402, Israel / BioPhorum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.govezensky@btgil.com
Jim Cannon
7 Mettler-Toledo Thornton, Inc., 900 Middlesex Turnpike, Building 8, Billerica, MA 01821 / PEMM;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jim.cannon@mt.com
Philip Villari
8 Merck & Co., Inc., Kenilworth, NJ, USA / BioPhorum / PEMM;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: philip_villari@merck.com
Anthony M Cundell
9 Microbiological Consulting, LLC., Rye, NY 10580 USA / PEMM;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tonycundell@gmail.com
Victoria Navarro
10 Pfizer, S. S. de los Reyes, Madrid, Spain / BioPhorum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: victoria.navarrolahoz@pfizer.com
Margit Franz-Riethdorf
11 BioPhorum Operations Group Limited, 5 Westbrook Court, Sharrowvale Road, Sheffield, S11 8YZ, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: margit.franz-riethdorf@biophorum.com
Allison Scott
12 Azbil North America Research and Development: BioVigilant, 2005 W. Ruthrauff Rd. #151, Tucson, AZ 85705 USA / PEMM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: awilhelmscott@gmail.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2022.012790
DOI 
https://doi.org/10.5731/pdajpst.2022.012790
PubMed 
37451837

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received August 3, 2022
  • Accepted July 3, 2023
  • Published online July 14, 2023.

Article Versions

  • You are currently viewing a previous version of this article (July 14, 2023 - 05:53).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2023, Parenteral Drug Association

Author Information

  1. Joanny Salvas1 (joanny.salvas{at}pfizer.com),
  2. Petra Merker2 (petra.merker{at}bayer.com),
  3. Mike Dingle3 (michael.dingle{at}tsi.com),
  4. Cedric Joossen4 (cjoossen{at}its.jnj.com),
  5. Chris Knutsen5 (chris.knutsen{at}bms.com),
  6. David Govezensky6 (david.govezensky{at}btgil.com),
  7. Jim Cannon7 (jim.cannon{at}mt.com),
  8. Philip Villari8 (philip_villari{at}merck.com),
  9. Anthony M Cundell9 (tonycundell{at}gmail.com),
  10. Victoria Navarro10 (victoria.navarrolahoz{at}pfizer.com),
  11. Margit Franz-Riethdorf11,13 (margit.franz-riethdorf{at}biophorum.com) and
  12. Allison Scott12 (awilhelmscott{at}gmail.com)
  1. 1 Pfizer, Kirkland, QC, Canada / BioPhorum;
  2. 2 Bayer AG, Mullerstr. 178, D-13353 Berlin, Germany / BioPhorum;
  3. 3 TSI Incorporated, 500 Cardigan Road, Shoreview, MN 55126 USA / PEMM;
  4. 4 Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium / OWBA;
  5. 5 Bristol-Myers Squibb, New Brunswick, NJ, USA / BioPhorum;
  6. 6 Bio-Technology General (Israel) Ltd., POB 571, Be'er Tuvia Industrial Zone, Kiryat Malachi 8310402, Israel / BioPhorum;
  7. 7 Mettler-Toledo Thornton, Inc., 900 Middlesex Turnpike, Building 8, Billerica, MA 01821 / PEMM;
  8. 8 Merck & Co., Inc., Kenilworth, NJ, USA / BioPhorum / PEMM;
  9. 9 Microbiological Consulting, LLC., Rye, NY 10580 USA / PEMM;
  10. 10 Pfizer, S. S. de los Reyes, Madrid, Spain / BioPhorum;
  11. 11 BioPhorum Operations Group Limited, 5 Westbrook Court, Sharrowvale Road, Sheffield, S11 8YZ, UK;
  12. 12 Azbil North America Research and Development: BioVigilant, 2005 W. Ruthrauff Rd. #151, Tucson, AZ 85705 USA / PEMM
  1. ↵* Corresponding author; email: margit.franz-riethdorf{at}biophorum.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 77 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 77, Issue 6
November/December 2023
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit
Joanny Salvas, Petra Merker, Mike Dingle, Cedric Joossen, Chris Knutsen, David Govezensky, Jim Cannon, Philip Villari, Anthony M Cundell, Victoria Navarro, Margit Franz-Riethdorf, Allison Scott
PDA Journal of Pharmaceutical Science and Technology Jul 2023, pdajpst.2022.012790; DOI: 10.5731/pdajpst.2022.012790

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit
Joanny Salvas, Petra Merker, Mike Dingle, Cedric Joossen, Chris Knutsen, David Govezensky, Jim Cannon, Philip Villari, Anthony M Cundell, Victoria Navarro, Margit Franz-Riethdorf, Allison Scott
PDA Journal of Pharmaceutical Science and Technology Jul 2023, pdajpst.2022.012790; DOI: 10.5731/pdajpst.2022.012790
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Accurate or Protective: What is the Goal of Non-targeted Extractables and Leachables Quantitation and Identification?
  • Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and other Drug Device Combination Products
Show more Commentary

Similar Articles

Keywords

  • Alternative and rapid microbial methods
  • Auto-Fluorescent Units
  • Bio-fluorescent particle counters

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire